Close

Laborie Launches alpHaONE, an Innovative GERD Diagnostic System

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Thermo Fisher Gets FDA Approval for...

The world leader when it comes to serving science,...

Virtual MRI Imaging with AI Aids...

During the magnetic resonance imaging (MRI) procedures, contrast agents...

New WHO-Listed Authorities Designated for Quality...

For the first time, the World Health Organization has...

Dynacare, Evexia to Start Health Testing...

Dynacare, which happens to be one of the leading...

Leading diagnostic and therapeutic medical technology company, Laborie Medical Technologies Corp. (Laborie), announced the launch of the alpHaONE system that is specifically designed to diagnose gastroesophageal reflux disease (GERD) and offers up to 96 hours of monitoring data.

GERD is a chronic medical condition caused by the flow of contents from the stomach upwards into the esophagus resulting in both symptoms and complications. It is estimated that 20% of the US population suffers from GERD with the most common symptoms being heartburn and regurgitation1.

With an increasing number of options for GERD diagnosis, patients and healthcare providers face a challenge in choosing the best solution for a clear diagnosis. alpHaONE offers a unique solution with its ergonomic and compact design, enlarged and easy-to-press buttons, and fail-safe capsule delivery system that protects the patient’s esophagus.

“alpHaONE is a patient-centric system that allows for comfortable monitoring and accurate, reliable data, fulfilling the needs of both patients and healthcare providers to diagnosis GERD,” said Rhett Klein, Vice President of Sales and Marketing for Laborie’s GI Business Unit. “Our primary objective has always been to provide solutions that elevate patient outcomes and enhance their overall experience and we look forward to launching this product.”

The comprehensive software application incorporated in the alpHaONE system consists of a Virtual Instruction Program, which allows for effortless navigation. In addition, user-customizable symptom buttons and automatic pH data analysis ensure a seamless user experience.

 

Latest stories

Related stories

Thermo Fisher Gets FDA Approval for NSCLC Treatment

The world leader when it comes to serving science,...

Virtual MRI Imaging with AI Aids Better Tumor Detection

During the magnetic resonance imaging (MRI) procedures, contrast agents...

New WHO-Listed Authorities Designated for Quality Assurance

For the first time, the World Health Organization has...

Dynacare, Evexia to Start Health Testing Services in Canada

Dynacare, which happens to be one of the leading...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back